App-Quantinova.ai

1151 Abstracts

A Challenging Case of Acute Tubular Necrosis Mimicking Lupus Nephritis in a Patient with Systemic Lupus Erythematosus (SLE)

H. Asif - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Excipient Lung Disease Complicated by Pulmonary Capillary Hemangiomatosis

H. Boucekkine - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

Hydroxychloroquine

The Diagnostic Challenge of Systemic Lupus Erythematosus

C. Gauvin - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Lupus

Hydroxychloroquine

Risk Factors for Hospital-Readmission After Treatment for COVID-19 Infection: A Retrospective Case-Control Study

W. Khan - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

A Case of Shrinking Lung Syndrome in a 51 Year-Old Female

D. M. Roelofsz - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

Hydroxychloroquine

Pulmonary Strongyloides in an Immunocompromised Patient

M. Abu-Rmaileh - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

A Predictive Model for Optimizing Survival with Therapeutic Enoxaparin and Steroids in the Treatment of COVID-19 Mechanically Ventilated Patients: When Do Benefits Outweigh Risk?

K. Johnson - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic

Moraima Jimenez - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hematological malignancies

Hydroxychloroquine

CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients

Fabian Mueller - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

COVID-19 Medications and Adherence to Treatment Guidelines in Hospitalized Children

Julianne E. Burns - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Functional Characterization of Disease-Associated ABCA3 Variants in a Human Pulmonary Epithelial Cell Line

Jennifer Wambach - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Hydroxychloroquine

Filters

1151 Abstracts